Browse All

Current Filters

CLEAR FILTER x

TITLE

Comparing First-line Natalizumab and Ocrelizumab Use for the Treatment of Multiple Sclerosis: A Komodo Health Claims Database Study

Author:Kaplan, Jeffrey   Beenstock, Dana   Belkin, Martin   Crayton, Heidi   Eckstein, Christopher   Fredericks, Ruth   Bian, Boyang   Belviso, Nicholas   Ni, Daphne   Rutledge, Danette   

Session Name:P7: Multiple Sclerosis: Disease-modifying Therapies: Real-world Evidence and Adverse Events 1  

Topic:Multiple Sclerosis  

Program Number:P7.012  

Author Institution:Kansas City MS Center, Overland Park, KS  Linda E. Cardinale Multiple Sclerosis Center, Freehold, NJ  Michigan Institute for Neurological Disorders, Farmington Hills, MI  MS Center of Greater Washington, Vienna, VA  Duke University, Durham, NC  St. Dominic Neuroscience Center, Jackson, MS  Biogen, Cambridge, MA